Drug intelligence / Profile preview

Qiye Shenan

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Qiye Shenan (also referred to as "Qiye Shen’an" or "Qiye Shen’an Pian") is a traditional Chinese medicine product formulated as dispersible tablets. It has been studied in combination with diazepam for the treatment of anxiety and insomnia. The product is not registered with certain regulatory authorities such as the Philippine FDA, which has issued warnings regarding its unregistered status and potential safety concerns. The precise herbal composition and mechanism of action are not fully detailed in available English-language sources; however, it is used within the context of traditional Chinese medicine for neuropsychiatric indications such as anxiety-related insomnia[1][2].

Brand names: Qiye Shenan Pian
Other names: Qiye Shen’anQiye Shen’an PianOTC Qiye Shen’an Pian

Beyond the preview

Go deeper on Qiye Shenan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiye Shenan.

Explore the full profile